RVNC - Revance Therapeutics, Inc.
IEX Last Trade
3.075
0 0%
Share volume: 19,297
Last Updated: Thu 26 Dec 2024 08:30:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$3.08
0.00
0.00%
Summary score
17%
Profitability
0%
Dept financing
11%
Liquidity
75%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.44%
Return on assets
-12.85%
Return on sales
-19098.66%
Return on invested capital
-355.68%
Total debt ratio
26.34%
Debt ratio change over timeo
-1%
Current Ratio
8.93%
Quick Ratio
10.46%
Cash Position Ratio
3.96%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-22.81%
Return on assets
-12.44%
Return on sales
-19098.66%
Return on invested capital
-618.83%
Total debt ratio
45.11%
Debt ratio change over timeo
-1.11%
Current Ratio
9.16%
Quick Ratio
10.46%
Cash Position Ratio
5.09%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-23.69%
Return on assets
-9.91%
Return on sales
-19098.66%
Return on invested capital
-238.38%
Total debt ratio
55.62%
Debt ratio change over time
-1.3%
Current Ratio
10.48%
Quick Ratio
10.46%
Cash Position Ratio
7.57%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-101.93%
Return on assets
-101.92%
Return on sales
10030.47%
Return on invested capital
59.88%
Total debt ratio
-99.5%
Debt ratio change over time
-1%
Current Ratio
0.04%
Quick Ratio
-6.55%
Cash Position Ratio
-0.78%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RVNC | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -18.44% | 17.45% | 19.89% | 4.69% |
| Return on assets | -12.85% | 3.37% | 11.41% | 3.35% |
| Return on sales | -19098.66% | 23.96% | 42.05% | 25.96% |
| Return on invested capital | -355.68% | 5.2% | -272.99% | 4.37% |
| Profitability | 0% | 69% | 75% | 50% |
| Total debt ratio | 26.34% | 77% | 53.92% | 57.66% |
| Debt ratio change over time | -1% | 0.36% | -1.16% | 10.77% |
| Dept financing | 9% | 26% | 18% | 44% |
| Current Ratio | 9.16% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 10.46% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 5.09% | 0.17% | 0.31% | 0.53% |
| Liquididy | 75% | 8% | 7% | 12% |
| Short-term ratios | RVNC | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -22.81% | 44.06% | 17.3% | 6.24% |
| Return on assets | -12.44% | 3.88% | 9.33% | 3.22% |
| Return on sales | -19098.66% | 27.04% | 40.02% | 24.93% |
| Return on invested capital | -618.83% | 9.69% | -224.06% | 4.96% |
| Profitability | 0% | 77% | 60% | 41% |
| Total debt ratio | 45.11% | 91.8% | 55.88% | 61.39% |
| Debt ratio change over time | -1.11% | 8.35% | -0.88% | 10.36% |
| Dept financing | 12% | 45% | 15% | 42% |
| Current Ratio | 9.16% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 10.46% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 5.09% | 0.17% | 0.31% | 0.53% |
| Liquididy | 75% | 6% | 6% | 8% |